Yee Vang
Family · Sacramento, CANPI 1952969388
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 184 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,521 and has fallen 87.2% since, to $195 in 2025. Among family clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 184 payments — averaging $21.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$572
- AbbVie$557
- Edwards Lifesciences$486
- Boehringer Ingelheim$261
- Novo Nordisk$250
- Johnson & Johnson$236
- plus $2K from 28 others
What the payments were for
- Food & beverage$3,985100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 28 | $572 |
| AbbVie | 32 | $557 |
| Edwards Lifesciences | 5 | $486 |
| Boehringer Ingelheim | 14 | $261 |
| Novo Nordisk | 14 | $250 |
| Johnson & Johnson | 16 | $236 |
| Lilly USA, LLC | 14 | $193 |
| Bayer | 6 | $173 |
| Merck | 6 | $129 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $120 |
| Eisai Inc. | 6 | $113 |
| Ironshore Pharmaceuticals Inc. | 1 | $103 |
| Novartis | 4 | $75 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $66 |
| Shockwave Medical, Inc | 2 | $59 |
| Vanda Pharmaceuticals Inc. | 2 | $51 |
| Therapeuticsmd, Inc. | 2 | $46 |
| IBSA Pharma Inc. | 3 | $46 |
| Amgen | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Upsher-smith Laboratories LLC | 2 | $42 |
| Boston Scientific | 2 | $40 |
| Esperion Therapeutics, Inc. | 2 | $38 |
| Abbott | 2 | $37 |
| Biohaven Pharmaceuticals, Inc. | 2 | $34 |
| Hologic Sales And Service, LLC | 2 | $34 |
| Sanofi-aventis U.S. LLC | 2 | $25 |
| AstraZeneca | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Nevro Corp. | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Medtronic | 1 | $13 |
| Corcept Therapeutics | 1 | $13 |
| Aquestive Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SAPIEN 3 Ultra RESILIA$189
- EVOQUE$159
- XIFAXAN$120
- JORNAY PM$103
How this compares
$3,985 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 14 | $245 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $243 |
| Ibuprofen | 15 | $132 |
| Amlodipine Besylate | 13 | $124 |
| Lisinopril | 11 | $115 |
Paid to pharmacies, not to this prescriber.
Other family in Sacramento
- Kim SchaferSacramento$288K
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
- Gabriel SchwartzSan Francisco$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.